Drug Shortage Report for TEVA-GLICLAZIDE
Report ID | 88164 |
Drug Identification Number | 02238103 |
Brand name | TEVA-GLICLAZIDE |
Common or Proper name | GLICLAZIDE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | GLICLAZIDE |
Strength(s) | 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 & 500 |
ATC code | A10BB |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2019-07-02 |
Estimated end date | 2020-07-31 |
Actual end date | 2020-07-22 |
Shortage status | Resolved |
Updated date | 2020-07-23 |
Company comments | Delays getting API for next lots. Allocating to 100% of our market. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v27 | 2020-03-26 | French | Compare |
v26 | 2020-03-26 | English | Compare |
v25 | 2020-03-26 | French | Compare |
v24 | 2020-03-26 | English | Compare |
v23 | 2020-01-24 | French | Compare |
v22 | 2020-01-24 | English | Compare |
v21 | 2020-01-09 | French | Compare |
v20 | 2020-01-09 | English | Compare |
v19 | 2019-12-05 | French | Compare |
v18 | 2019-12-05 | English | Compare |
v17 | 2019-10-31 | French | Compare |
v16 | 2019-10-31 | English | Compare |
v15 | 2019-10-24 | French | Compare |
v14 | 2019-10-24 | English | Compare |
v13 | 2019-10-17 | French | Compare |
v12 | 2019-10-17 | English | Compare |
v11 | 2019-09-19 | French | Compare |
v10 | 2019-09-19 | English | Compare |
v9 | 2019-08-29 | French | Compare |
v8 | 2019-08-29 | English | Compare |